FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W99595538> ?p ?o ?g. }

• W99595538 startingPage "107" @default.
• W99595538 abstract "Abstract: Competing interests and values collide at the intersection of public health, international trade, and intellectual property. Although highly successful in securing rigid patent protection provisions in the Agreement on Trade Related Aspects on Intellectual Property Rights (TRIPS), the United States was dissatisfied with features of the agreement. In response, the United States began to negotiate bilateral free trade agreements which, while compliant with the TRIPS Agreement, include unflinchingly rigid intellectual property provisions. This Note argues that invidious TRIPS-Plus provisions in U.S. Free Trade Agreements, which require greater patent protections than the TRIPS Agreement, obstruct access to affordable pharmaceuticals desperately needed by impoverished populations around the globe. To encourage access to affordable drugs in low-income countries, the United States should amend its free trade agreements by incorporating a balancing test to determine when it is necessary to relax rigid trade provisions.IntroductionOn November 7, 1991, Earvin Magic Johnson, an all-star basket- ball player for the Los Angeles Lakers, announced his retirement from the National Basketball Association (NBA).1 Johnson had recently been diagnosed with the Human Immunodeficiency Virus (HIV), which causes Acquired Immune Deficiency Syndrome (AIDS).2 Winner of five NBA championships, a twelve-time All-Star, league most valuable player (MVP), and three-time NBA Finals MVP, Johnson was at the pinnacle of his profession.3 Disclosing his diagnosis shocked the world and many thought the end of Johnson's storied NBA career also meant the end of his life.4 After all, in the early 1990s, treatment for HIV/AIDS was rare and diagnosis was considered a death sentence.5 In fact, before 1996, an estimated fifty percent of those diagnosed with HIV would develop AIDS within ten years.6Twenty years later, Johnson is a thriving fifty-two-year-old.7 On No- vember 7, 2011, Johnson celebrated with athletes, politicians, research- ers, and celebrities as his foundation pledged a one million dollar gift to promote continued HIV/AIDS awareness and testing.8 Upon his ini- tial diagnosis, Johnson took nearly twenty pills a day to manage the dis- ease, but thanks to breakthroughs in the pharmaceutical industry, Johnson is now on highly effective antiretroviral therapy (HAART), which requires only a few daily medications.9 Antiretroviral therapy prolongs life and improves the health of those infected with HIV/AIDS.10 On that somber November day in 1991, Johnson defiantly proclaimed that he would 'beat the disease.'11 Twenty years later, ac- cess to HAART has enabled Johnson's proclamation to ring true.12A world away in Bwindi, Uganda, Hope Tukahirwa has not been as fortunate.13 Tukahirwa's husband and son both contracted AIDS and died before HAART was even nominally available in sub-Saharan Af- rica.14 Like Johnson, Tukahirwa contracted HIV and currently receives antiretroviral therapy.15 Unlike Johnson, however, Tukahirwa's access to HAART hangs in a tenuous balance as trade laws dictate her ability to procure treatment.16 Tukahirwa understands that HAART has pro- longed her life and she expresses concern about the effect of trade laws on her access to this life-saving therapy.17 'In the old days, people were dying like rats. The drugs were too expensive and if it happened again we would be back in the old days.'18Infectious diseases plague the developing world.19 By the end of 2009, an estimated 33.3 million people were living with HIV/AIDS.20 Of that total, 22.5 million live in sub-Saharan Africa, 4.1 million live in Southeast Asia, and 1.4 million live in Central and South America, demonstrating a disproportionate impact on low and middle-income countries (LMICs).21 In 2009, approximately 1.8 million people died from AIDS-related causes, contributing to an estimated 16.6 million children orphaned from HIV/AIDS.22 The disease continues to spread as approximately 2. …" @default.
• W99595538 created "2016-06-24" @default.
• W99595538 creator A5076717317 @default.
• W99595538 date "2013-01-01" @default.
• W99595538 modified "2023-09-23" @default.
• W99595538 title "Magic and Hope: Relaxing Trips-Plus Provisions to Promote Access to Affordable Pharmaceuticals" @default.
• W99595538 hasPublicationYear "2013" @default.
• W99595538 type Work @default.
• W99595538 sameAs 99595538 @default.
• W99595538 citedByCount "1" @default.
• W99595538 countsByYear W995955382015 @default.
• W99595538 crossrefType "journal-article" @default.
• W99595538 hasAuthorship W99595538A5076717317 @default.
• W99595538 hasConcept C121332964 @default.
• W99595538 hasConcept C127413603 @default.
• W99595538 hasConcept C1276947 @default.
• W99595538 hasConcept C144133560 @default.
• W99595538 hasConcept C155202549 @default.
• W99595538 hasConcept C157085824 @default.
• W99595538 hasConcept C17744445 @default.
• W99595538 hasConcept C199539241 @default.
• W99595538 hasConcept C199776023 @default.
• W99595538 hasConcept C207456731 @default.
• W99595538 hasConcept C22212356 @default.
• W99595538 hasConcept C2780454388 @default.
• W99595538 hasConcept C34974158 @default.
• W99595538 hasConcept C35532855 @default.
• W99595538 hasConceptScore W99595538C121332964 @default.
• W99595538 hasConceptScore W99595538C127413603 @default.
• W99595538 hasConceptScore W99595538C1276947 @default.
• W99595538 hasConceptScore W99595538C144133560 @default.
• W99595538 hasConceptScore W99595538C155202549 @default.
• W99595538 hasConceptScore W99595538C157085824 @default.
• W99595538 hasConceptScore W99595538C17744445 @default.
• W99595538 hasConceptScore W99595538C199539241 @default.
• W99595538 hasConceptScore W99595538C199776023 @default.
• W99595538 hasConceptScore W99595538C207456731 @default.
• W99595538 hasConceptScore W99595538C22212356 @default.
• W99595538 hasConceptScore W99595538C2780454388 @default.
• W99595538 hasConceptScore W99595538C34974158 @default.
• W99595538 hasConceptScore W99595538C35532855 @default.
• W99595538 hasIssue "1" @default.
• W99595538 hasLocation W995955381 @default.
• W99595538 hasOpenAccess W99595538 @default.
• W99595538 hasPrimaryLocation W995955381 @default.
• W99595538 hasRelatedWork W1573080118 @default.
• W99595538 hasRelatedWork W1807277265 @default.
• W99595538 hasRelatedWork W1987013923 @default.
• W99595538 hasRelatedWork W2010541732 @default.
• W99595538 hasRelatedWork W2029401251 @default.
• W99595538 hasRelatedWork W2029952413 @default.
• W99595538 hasRelatedWork W2077056974 @default.
• W99595538 hasRelatedWork W2081023221 @default.
• W99595538 hasRelatedWork W2171233176 @default.
• W99595538 hasRelatedWork W2332890878 @default.
• W99595538 hasRelatedWork W310376944 @default.
• W99595538 hasRelatedWork W815102880 @default.
• W99595538 hasRelatedWork W175496379 @default.
• W99595538 hasRelatedWork W2197675609 @default.
• W99595538 hasRelatedWork W2210954870 @default.
• W99595538 hasRelatedWork W2252634048 @default.
• W99595538 hasRelatedWork W2279055807 @default.
• W99595538 hasRelatedWork W2293016693 @default.
• W99595538 hasRelatedWork W2294569740 @default.
• W99595538 hasRelatedWork W2991844656 @default.
• W99595538 hasVolume "33" @default.
• W99595538 isParatext "false" @default.
• W99595538 isRetracted "false" @default.
• W99595538 magId "99595538" @default.
• W99595538 workType "article" @default.